tricular cardiomyopathy (ARVC) is a myocardial disorder characterised clinically by ventricular arrhythmias that can cause cardiac arrest and morphologically by fatty or fibro-fatty myocardial atrophy of the right ventricle. In vivo tissue characterisation without endomyocardial biopsy would be useful. The aim of this study was to investigate the diagnostic accuracy of spin-echo nuclear magnetic resonance (NMR) for tissue characterisation in ARVC. Patients and methods-Twenty three subjects (15 men and eight women, aged 18-49, mean 34) were studied with spinecho Ti-weighted NMR and multislice scan. Fifteen had a clinical diagnosis of ARVC and eight were controls (age and sex matched subjects). Data were independently evaluated by two expert observers. Results-In the control group NMR was always negative (100% specificity). Ten of the 15 patients with ARVC had an abnormal NMR result (67% sensitivity), with areas that had a signal intensity close to that of pericardial or subcutaneous fat. In the remaining five cases the NMR signal was inadequate. Nine An abnormally hyperintense bright signal was detected in 10 out of 15 (sensitivity 67%) patients. In the remaining five, the NMR signal was considered to be inadequate and not informative.
The anterolateral free wall of the right ventricle was affected in all NMR positive patients, the inferior wall in six, the apex in seven, and the outflow tract in seven (fig 1) . Five patients showed a diffuse involvement of the right ventricle (free wall, inferior, apex, outflow tract), with a significant enlargement of the right ventricular chamber. Furthermore, the right ventricular wall was thin in three and there was an irregular endocardial outline in two.
NMR was always normal at the level of interventricular septum and only one patient had involvement of the left ventricular free wall, showing both a hyperintense signal and cavity enlargement. Evaluating the NMR signal intensity at the level of anterolateral right ventricular free wall was particularly difficult.
We never saw the clear low intensity dark signal that indicates fibrous tissue replacement.
Nine patients, with a diagnosis of ARVC, had both NMR and endomyocardial biopsy (table 2). In eight (89%) endomyocardial biopsy confirmed ARVC, caused by fibrofatty replacement in three and isolated fibrous replacement in five (fig 2) . Spin-echo NMR was positive in five (56%) and equivocal in four because of an inadequate signal. Among these four endomyocardial biopsy was positive in three with isolated fibrous replacement and negative in one. 
